Cresco Labs (CRLBF) Consolidated Net Income (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Consolidated Net Income came in at $11.4 million in Q1 2026, down 14.72% YoY from $13.4 million in Q1 2025, and up 113.39% on a QoQ basis from -$85.3 million in Q4 2025.
Cresco Labs (CRLBF) Consolidated Net Income (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Consolidated Net Income data on file, last reported at $11.4 million in Q1 2026.
- Quarterly Consolidated Net Income fell 14.72% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.8 million (down 382.13% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
- Consolidated Net Income advanced to $11.4 million in Q1 2026, from -$85.3 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $39.0 million in Q2 2022 to a low of -$133.1 million in Q4 2022.
- A 5-year average of -$8.9 million and a median of $11.4 million in 2026 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income surged 498.53% — and 2025, when it slumped 1604.87%.
- Tracing CRLBF's Consolidated Net Income over 5 years: stood at -$133.1 million in 2022, then surged by 115.6% to $20.8 million in 2023, then slumped by 72.69% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then jumped by 113.39% to $11.4 million in 2026.
- The last three Consolidated Net Income figures came in at $11.4 million (Q1 2026), -$85.3 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | -22.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.43 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 19.38 Mn |
| Mar 31, 2025 | 13.40 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 30.34 Mn |
| Jun 30, 2024 | -30.70 Mn |
| Mar 31, 2024 | 33.95 Mn |
| Dec 31, 2023 | 20.77 Mn |
| Sep 30, 2023 | -124.94 Mn |
| Jun 30, 2023 | -15.59 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | -133.10 Mn |
| Sep 30, 2022 | 34.22 Mn |
| Jun 30, 2022 | 38.98 Mn |
| Mar 31, 2022 | 21.94 Mn |
| Dec 31, 2021 | 35.15 Mn |
| Sep 30, 2021 | -219.60 Mn |
| Jun 30, 2021 | 29.58 Mn |